BioMarin to Participate in Four Upcoming Investor Conferences in March
Rhea-AI Summary
BioMarin (NASDAQ: BMRN) announced management will participate in four investor conferences in March 2026: TD Cowen (Mar 4), Leerink (Mar 9), Jefferies Biotech on the Bay (Mar 10) and Barclays Global Healthcare (Mar 11).
Executives will take part in fireside chats, 1x1 meetings, and live webcasts; replay will be available for a limited time.
Positive
- None.
Negative
- None.
- TD Cowen 46th Annual Health Care Conference on Wednesday, March 4, 2026
- Leerink 2026 Global Healthcare Conference on Monday, March 9, 2026
- Jefferies 2026 Biotech on the Beach Summit on Tuesday, March 10, 2026
- Barclays 28th Annual Global Healthcare Conference on Wednesday, March 11, 2026
TD Cowen 46th Annual Health Care Conference (
- Wednesday, March 4th, Alexander Hardy, President & Chief Executive Officer and Brian Mueller, Executive Vice President, Chief Financial Officer will participate in a fireside chat at 10:30am ET and host 1x1 meetings
Leerink 2026 Global Healthcare Conference (
- Monday, March 9th, Cristin Hubbard, Executive Vice President, Chief Commercial Officer and Brian Mueller, Executive Vice President, Chief Financial Officer will participate in a fireside chat at 8:00am ET and host 1x1 meetings
Jefferies 2026 Biotech on the Bay Summit (
- Tuesday, March 10th, Cristin Hubbard, Executive Vice President, Chief Commercial Officer and Brian Mueller, Executive Vice President, Chief Financial Officer will host 1x1 meetings
Barclays 28th Annual Global Healthcare Conference (
- Wednesday, March 11th, Cristin Hubbard, Executive Vice President, Chief Commercial Officer and Brian Mueller, Executive Vice President, Chief Financial Officer will participate in a fireside chat at 2:00pm ET and host 1x1 meetings
The fireside chats will be webcast live and can be accessed by visiting BioMarin's website at https://investors.biomarin.com/. A webcast replay will be available through the Company's website for a limited time following the conferences.
About BioMarin
BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael,
Contacts: | |
Investors | Media |
Traci McCarty | Marni Kottle |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (650) 374-2803 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-four-upcoming-investor-conferences-in-march-302695288.html
SOURCE BioMarin Pharmaceutical Inc.